To read this content please select one of the options below:

US push, not IP waiver, will raise vaccine supply

Content type:: Executive Summary
Location:: INTERNATIONAL
Keywords associated with this article:: Geographic: International INT

Topical: economy foreign investment foreign trade health pharmaceutical regulation welfare
ISSN:: 2633-304X
Citation:: Oxford Analytica (2021), "US push, not IP waiver, will raise vaccine supply", Expert Briefings.
https://doi.org/10.1108/OXAN-ES261328

Thursday, May 6, 2021

Headline

INTERNATIONAL: US push, not IP, will increase vaccines

Related articles